Rupali Jain
-
- Antibiotic Use and Resistance 15
- Molecular Medicine top 1%
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility 9
- Antimicrobial Resistance in Staphylococcus 8
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy 13
- Endocrinology top 5%
-
- Bacterial Identification and Susceptibility Testing 11
-
- Neutropenia and Cancer Infections 9
-
- Pneumocystis jirovecii pneumonia detection and treatment 5
- Pneumonia and Respiratory Infections 5
- Co-authors
- Larry H. DanzigerPaul S. PottingerRobert M. RakitaDavid N. FredricksAyesha AppaShahin HakimianHelen Y. ChuHu Xie
- Journals
- Open Forum Infectious Diseases (11 papers)Infection Control and Hospital Epidemiology (5 papers)Clinical Infectious Diseases (2 papers)
- Partner nations
- United StatesSouth AfricaBelgium
In The Last Decade
Rupali Jain
51 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 100
- Applied Microbiology and Biotechnology 144
- Molecular Medicine 335
- Infectious Diseases 412
- Pharmacology 322
- Endocrinology 79
Countries citing papers authored by Rupali Jain
This map shows the geographic impact of Rupali Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupali Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupali Jain more than expected).
Fields of papers citing papers by Rupali Jain
This network shows the impact of papers produced by Rupali Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupali Jain. The network helps show where Rupali Jain may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rupali Jain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 7 | |
| 11 | 2022 | 6 | |
| 12 | 2018 | 5 | |
| 13 | 2018 | 7 | |
| 14 | 2017 | 4 | |
| 15 | 2017 | 71 | |
| 16 | 2017 | 4 | |
| 17 | 2013 | 26 | |
| 18 | 2009 | 4 | |
| 19 | 2007 | 17 | |
| 20 | 2004 | 96 |
About Rupali Jain
Rupali Jain is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry and Infectious Diseases, having authored 55 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (15 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers), Bacterial Identification and Susceptibility Testing (11 papers), Antifungal resistance and susceptibility (9 papers), Neutropenia and Cancer Infections (9 papers), Antimicrobial Resistance in Staphylococcus (8 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and Pneumonia and Respiratory Infections (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (144 citations), Molecular Medicine (335 citations) and Infectious Diseases (412 citations). Rupali Jain has collaborated with scholars based in United States, South Africa and Belgium. Frequent co-authors include Larry H. Danziger, Paul S. Pottinger, Robert M. Rakita, David N. Fredricks, Ayesha Appa, Shahin Hakimian, Helen Y. Chu, Hu Xie, Samuel L Aitken and John B. Lynch. Their work appears in journals such as Open Forum Infectious Diseases, Infection Control and Hospital Epidemiology, Clinical Infectious Diseases, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and Journal of the National Comprehensive Cancer Network.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.